Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Digital Neuro Biomarkers Market Expansion From $1.22 Billion In 2026 To $3.19 Billion In 2030
The digital neuro biomarkers market size has observed significant expansion in recent years. It is forecast to grow from $0.95 billion in 2025 to $1.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 27.5%. The historical growth of this market stems from factors such as the increasing prevalence of neurological disorders, the rising adoption of wearable devices, a stronger focus on cognitive assessment, advancements in neuroimaging technologies, and early research endeavors in digital biomarker development.
The digital neuro biomarkers market is expected to experience significant growth over the next few years. It is projected to expand to $3.19 billion by 2030, achieving a compound annual growth rate (CAGR) of 27.2%. This growth during the forecast period is attributable to the increasing incorporation of artificial intelligence in neurological diagnostics, a rising demand for remote patient monitoring, the broadening of tele-neurology services, increased investments in neuroscience research, and the development of personalized neurology treatment solutions. Key trends in the upcoming period include the enhanced utilization of cloud-based neurological data analytics, the adoption of real-time brain monitoring technologies, the proliferation of mobile cognitive assessment applications, the integration of machine learning in biomarker analysis, and the rise of predictive and precision neurology platforms.
Download A Free Sample Report For Comprehensive Market Insights:
#Digital Neuro Biomarkers Market Demand Drivers Creating New Revenue Opportunities
The heightened emphasis on the early detection and continuous monitoring of neurological disorders is expected to drive the growth of the digital neuro biomarkers market. This involves the utilization of digital technologies like wearable devices, mobile applications, and sensors to continuously assess neurological function, cognition, and behavior, thereby enabling the timely identification of neurological conditions. This focus is intensifying due to various public health initiatives and clinical priorities aimed at identifying cognitive impairment and neurodegenerative diseases before severe symptoms manifest. Digital neuro biomarkers support these efforts by providing objective, real-time data that assists clinicians and researchers in detecting subtle neurological changes and initiating early interventions. For instance, in 2024, the U.S. Centres for Disease Control and Prevention’s Healthy Brain Initiative highlights that neurological disorders affect approximately one billion people globally, including around 50 million individuals with epilepsy and 24 million with Alzheimer’s disease. Therefore, the increasing focus on the early detection and monitoring of neurological disorders through digital tools is propelling the expansion of the digital neuro biomarkers market.
Digital Neuro Biomarkers Market Segment Landscape: Which Areas Lead Market Development?
The digital neuro biomarkers market covered in this report is segmented –
1) By Type: Wearable, Mobile-Based Applications, Sensors, Other Types
2) By Deployment Mode: Cloud-Based Platforms, On-Premise Platforms, Hybrid Deployment Models
3) By Biomarker Type: Cognitive Digital Biomarkers, Motor Function Digital Biomarkers, Speech And Language Digital Biomarkers, Behavioral Digital Biomarkers
4) By End-User: Healthcare Companies, Healthcare Providers, Payers, Other End-Users
Subsegments:
1) By Wearable: Smart Wristbands, Smart Headbands, Smart Watches, Smart Clothing, Implantable Devices
2) By Mobile-Based Applications: Cognitive Assessment Applications, Neurological Monitoring Applications, Mental Health Tracking Applications, Motor Function Assessment Applications, Speech And Language Tracking Applications
3) By Sensors: Electroencephalography Sensors, Electrocardiography Sensors, Eye Tracking Sensors, Motion Tracking Sensors, Biometric Monitoring Sensors
4) By Other Types: Cloud Based Platforms, Data Analytics Tools, Digital Therapeutic Platforms, Artificial Intelligence Enabled Assessment Tools, Virtual Reality Based Assessment Tools
Digital Neuro Biomarkers Market Trends Driving Strategic Industry Expansion
Leading companies in the digital neuro biomarkers market are prioritizing the creation of open-access research infrastructure, such as WearGait PD, to facilitate the development, validation, and regulatory assessment of wearable-based digital neuro biomarkers for neurological disorders. WearGait PD is defined as a regulatory science dataset that offers synchronized wearable sensor and gait data from individuals with Parkinson’s disease and age-matched controls, making it possible to extract and evaluate gait-derived digital biomarkers for disease monitoring and progression evaluation. For example, in July 2024, the U.S. Food and Drug Administration (FDA), a U.S.-based regulatory agency, released “WearGait PD: Wearables Dataset for Gait in Parkinson’s Disease and Age-Matched Controls,” an open-access dataset intended to support researchers and industry developers in deriving and validating digital biomarkers. The dataset contains raw inertial measurement unit (IMU) acceleration and rotational velocity data, insole pressure recordings, and synchronized gait annotations, which aids in algorithm testing, metric validation, and the advancement of wearable sensor-based monitoring tools.
Digital Neuro Biomarkers Market Industry Leaders And Market Competition
Major companies operating in the digital neuro biomarkers market are F. Hoffmann-La Roche AG, Merck KGaA, Biogen Inc., Evidation Health Inc., Huma Therapeutics Limited, Altoida Inc, Cogstate Limited, Quibim S.L., Empatica Inc., Linus Health Inc., Cambridge Cognition Holdings plc, Brainomix Limited, Mindstrong Health Inc., Neurotrack Technologies Inc., Feel Therapeutics Inc., BrainCheck Inc., IXICO plc, NeuraMetrix Inc., NeuraLight Ltd., Koneksa Health Inc., Sonde Health Inc., Aural Analytics Inc., Winterlight Labs Inc.
Access The Complete Digital Neuro Biomarkers Market Report:
Digital Neuro Biomarkers Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the digital neuro biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital neuro biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model